OvAge
Catanzaro
About OvAge
OvAge is a unique and innovative methodology , provided through a web based software, result of the most advanced scientific research in the field of gynecology and infertility. OvAge is the first test that, with simplicity and precision, reveals the ovarian age of women. A revolutionary tool that improves the lives of all women, at any age. OvAge represents the evolution and convergence of current standards based on biochemical and ultrasound analyzes enhanced by the use of computer engineering. It offers great ease of reading in the results, providing a synthetic value - the ovarian age -, objective, universal (in scale) easy to use within a process of analysis often left to the subjectivity and experience of the specialist. It meets the emerging need, in the new female generations, to be able to "plan" adequately their desire / reproductive need, while still being young and pursuing their career development (so-called Family Planning).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $52.7K
- Last round: Grant (Jan 2017)
- Website: ovage.com
- Phone: +39 320 268 5518
Industries & Categories
Health Care, Health Diagnostics, Software
Social Profiles
Canonical: https://fsome.com/organization/ovage-2231325 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.